According to the president of Lombardy "for our health service damage of over 60 million euros"
«With a resolution adopted by the Council, the Lombardy Region has decided to initiate a series of legal actions against the Novartis and La Roche groups for the matter for which these two companies were sentenced by the Antitrust to a fine of over 180 million: the two companies would have favored the exclusive use of the drug "Lucentis", which has an average cost of around 900 euros, unfairly discouraging the use of a similar drug, "Avastin", having the same active ingredient, but with a cost of around 80 euros . According to the Antitrust, this would have caused damage to the National Health Service estimated, from 2009 onwards, in the hundreds and hundreds of millions». This was explained by the president of the Lombardy Region, Roberto Maroni, this morning, during the press conference at Palazzo Lombardia after the council meeting.
MANDATE GIVEN TO THE REGIONAL LAWYER'S SERVICE – «We have carried out a check as regards Lombardy - added President Maroni - and we have estimated damage to the regional health service of over 60 million euros, for which we have given the task of the regional lawyers' office to proceed legally against the two companies for the judicial or extrajudicial recovery of this amount. We hope that this amount will soon be added to what we have received, i.e. 506 million euros from the new allocation of the 2014 Health Fund, and a similar sum will arrive in 2015, thanks to the simple implementation of the standard costs through which we have this extraordinary advantage".
6/09/2014 – Lombardia VARESENEWS
